BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 24061989)

  • 1. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
    Chen CG; Cui L; Tang P; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
    Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
    Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
    Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
    Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
    BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.
    Cao X; Zhang L; Feng GR; Yang J; Wang RY; Li J; Zheng XM; Han YJ
    J Transl Med; 2012 Sep; 10():197. PubMed ID: 22999061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical signifinace of CEA, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
    Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy.
    Zhang HQ; Wang RB; Yan HJ; Zhao W; Zhu KL; Jiang SM; Hu XG; Yu JM
    Asian Pac J Cancer Prev; 2012; 13(1):199-203. PubMed ID: 22502668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
    Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
    Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
    Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J; Guo Z; Zhang L
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.
    Yi Y; Li B; Wang Z; Sun H; Gong H; Zhang Z
    Biomarkers; 2009 Nov; 14(7):480-5. PubMed ID: 19863186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
    Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
    BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
    Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
    J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.
    Kosugi S; Nishimaki T; Kanda T; Nakagawa S; Ohashi M; Hatakeyama K
    World J Surg; 2004 Jul; 28(7):680-5. PubMed ID: 15383868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.